Medicine/Drugs

Even though members of AACE generally treat more type 1s than type 2s, this treatment algorithm is designed specifically for

Sanofi The French drugmaker, which on Thursday reported first-quarter results, said it would provide a fresh timeline for the fixed-combination

Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today that the United States Food and Drug Administration (FDA) has

Merck & Co. entered into an up to $430 million collaboration with  Abide  diabetes  metabolic diseases Abide said today the

Diamyd Medical (former Diamyd Therapeutics) is a diabetes company headquartered in Stockholm, Sweden. The Company develops the diabetes vaccine Diamyd®and

A four-day-long World Congress of Diabetes organised by Diabetes India concluded recently in Kochi, and the outcome of it was

Eli Lilly ( $LLY On Tuesday Lilly marched out results from two Phase III studies of the GLP-1 contender, saying

Abide Therapeutics, a biopharmaceutical company pioneering innovative approaches to selectively target a group of enzymes known as serine hydrolases, today

Matthew Pfeffer - Chief Financial Officer, Principal Accounting Officer and Corporate Vice President Good afternoon and thank you for participating in

Merck & Co Inc reported disappointing first-quarter sales on a surprising downturn for its Januvia diabetes medicine, the company’s biggest

The American Diabetes Association released new research today, conducted by Harris Interactive(R), which examines the level of awareness and understanding

Transition Therapeutics Inc Patients treated with the experimental drug experienced statistically significant reductions in mean fasting blood glucose and mean

Eli Lilly, the world’s fourth-largest diabetes drugs maker, aims to have the widest range of anti diabetic drugs in order

Integration of obesity management in the treatment of patients with diabetes is one of the key recommendations highlighted in the

The  Food and Drug Administration GlaxoSmithKline drug Avandia Regulators announced the highly unusual move in a government notice published on

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company   The SGLT disease education initiative features the microsite  www.SGLT.com Glucose

A new diabetes drug that hit the market in the past week boasts it can drop your glucose levels and

Dr. George Fielding, a pioneer of weight loss surgery in Australia, remembers how patients treated him in the late 1990s,

The fixed combination of the drugs saxagliptin and metformin (Komboglyze®) has been approved in Germany since November 2011 for the

Pfizer Inc The Pfizer medicine belongs to a new class of diabetes treatments called SGLT2 inhibitors. Now nearing Phase III